The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis

References

• Lareau SC, Fahy B, Meek P, et al. Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 2019;199(1):P1–P2. doi:10.1164/rccm.1991P1
   PubMed Web of Science ®Google Scholar
• Nici L, Mammen MJ, Charbek E, et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(9):e56–e69. doi:10.1164/rccm.202003-0625ST
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36. doi:10.1164/rccm.202009-3533SO
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;394(10204):1145–1158. doi:10.1016/S0140-6736(19)30427-1
   PubMed Web of Science ®Google Scholar
• Soriano JB, Kendrick PJ, Paulson KR; GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-3
   PubMed Web of Science ®Google Scholar
• Feetham L, van Dorn A. Chronic obstructive pulmonary disease (COPD). Lancet Respir Med. 2017;5(1):18–19. doi:10.1016/S2213-2600(16)30442-8
   PubMed Web of Science ®Google Scholar
• Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166(3):314–322. doi:10.1164/rccm.2107027
   PubMed Web of Science ®Google Scholar
• Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127(5):1531–1536. doi:10.1378/chest.127.5.1531
   PubMed Web of Science ®Google Scholar
• Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(2):189–194. doi:10.1164/rccm.200401-006OC
   PubMed Web of Science ®Google Scholar
• Medrek SK, Sharafkhaneh A, Spiegelman AM, Kak A, Pandit LM. Admission for COPD exacerbation is associated with the clinical diagnosis of pulmonary hypertension: results from a retrospective longitudinal study of a veteran population. COPD. 2017;14(5):484–489. doi:10.1080/15412555.2017.1336209
   PubMedGoogle Scholar
• Wheaton AG, Cunningham TJ, Ford ES, Croft JB. Centers for Disease Control and Prevention (CDC). Employment and activity limitations among adults with chronic obstructive pulmonary disease–United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(11):289–295.
   PubMed Web of Science ®Google Scholar
• Olschewski H, Behr J, Bremer H, et al. Pulmonary hypertension due to lung diseases: updated recommendations from the cologne consensus conference 2018. Int J Cardiol. 2018;272S:63–68. doi:10.1016/j.ijcard.2018.08.043
   PubMed Web of Science ®Google Scholar
• Hirani N, Brunner NW, Kapasi A, et al. Canadian Cardiovascular Society/Canadian Thoracic Society position statement on pulmonary hypertension. Can J Cardiol. 2020;36(7):977–992. doi:10.1016/j.cjca.2019.11.041
   PubMed Web of Science ®Google Scholar
• Mueller-Mottet S, Stricker H, Domenighetti G, et al. Long-term data from the Swiss pulmonary hypertension registry. Respiration. 2015;89(2):127–140. doi:10.1159/000370125
   PubMed Web of Science ®Google Scholar
• Andersen KH, Iversen M, Kjaergaard J, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012;31(4):373–380. doi:10.1016/j.healun.2011.11.020
   PubMed Web of Science ®Google Scholar
• Hurdman J, Condliffe R, Elliot CA, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J. 2013;41(6):1292–1301. doi:10.1183/09031936.00079512
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012. doi:10.1001/jama.283.15.2008
   PubMed Web of Science ®Google Scholar
• Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19(4):170–176.
   PubMedGoogle Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed March 15, 2021.
   Google Scholar
• Luchini C, Stubbs B, Solmi M, et al. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa scale. World J Meta-Anal. 2017;5(4):80–84. doi:10.13105/wjma.v5.i4.80
   Google Scholar
• Mavridis D, Salanti G. How to assess publication bias: funnel plot, trim-and-fill method and selection models. Evid Based Ment Health. 2014;17(1):30. doi:10.1136/eb-2013-101699
   PubMedGoogle Scholar
• Hoffmann J, Wilhelm J, Olschewski A, Kwapiszewska G. Microarray analysis in pulmonary hypertension. Eur Respir J. 2016;48(1):229–241. doi:10.1183/13993003.02030-2015
   PubMed Web of Science ®Google Scholar
• Opitz I, Ulrich S. Pulmonary hypertension in chronic obstructive pulmonary disease and emphysema patients: prevalence, therapeutic options and pulmonary circulatory effects of lung volume reduction surgery. J Thorac Dis. 2018;10(Suppl 23):S2763–S2774. doi:10.21037/jtd.2018.07.63
   PubMed Web of Science ®Google Scholar
• Rahaghi FN, Argemí G, Nardelli P, et al. Pulmonary vascular density: comparison of findings on computed tomography imaging with histology. Eur Respir J. 2019;54(2):1900370. doi:10.1183/13993003.00370-2019
   PubMed Web of Science ®Google Scholar
• Washko GR, Nardelli P, Ash SY, et al. Arterial vascular pruning, right ventricular size, and clinical outcomes in chronic obstructive pulmonary disease a longitudinal observational study. Am J Respir Crit Care Med. 2019;200(4):454–461. doi:10.1164/rccm.201811-2063OC
   PubMed Web of Science ®Google Scholar
• Blanco I, Tura-Ceide O, Peinado VI, Barberà JA. Updated perspectives on pulmonary hypertension in COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:1315–1324. doi:10.2147/COPD.S211841
   PubMed Web of Science ®Google Scholar
• Bigna JJ, Noubiap JJ, Nansseu JR, Aminde LN. Prevalence and etiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis. BMC Pulm Med. 2017;17(1):183. doi:10.1186/s12890-017-0549-5
   PubMed Web of Science ®Google Scholar
• Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9947):1005–1070. doi:10.1016/S0140-6736(14)60844-8
   PubMed Web of Science ®Google Scholar
• Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383(9936):2253–2264. doi:10.1016/S0140-6736(13)61949-2
   PubMed Web of Science ®Google Scholar
• Bigna JJ, Nansseu JR, Um LN, et al. Prevalence and incidence of pulmonary hypertension among HIV-infected people in Africa: a systematic review and meta-analysis. BMJ Open. 2016;6(8):e011921. doi:10.1136/bmjopen-2016-011921
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Humbert M, Souza R, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4(4):306–322. doi:10.1016/S2213-2600(15)00543-3
   PubMed Web of Science ®Google Scholar
• Mocumbi AO, Thienemann F, Sliwa K. A global perspective on the epidemiology of pulmonary hypertension. Can J Cardiol. 2015;31(4):375–381. doi:10.1016/j.cjca.2015.01.030
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Huscher D, Ghofrani HA, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013;168(2):871–880. doi:10.1016/j.ijcard.2012.10.026
   PubMed Web of Science ®Google Scholar
• Valverde AB, Soares JM, Viana KP, Gomes B, Soares C, Souza R. Pulmonary arterial hypertension in Latin America: epidemiological data from local studies. BMC Pulm Med. 2018;18(1):106. doi:10.1186/s12890-018-0667-8
   PubMed Web of Science ®Google Scholar
• Kjellström B, Nisell M, Kylhammar D, et al. Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008–2016. ERJ Open Res. 2019;5(3):00075–2019. doi:10.1183/23120541.00075-2019
   PubMedGoogle Scholar
• Cheron C, McBride SA, Antigny F, et al. Sex and gender in pulmonary arterial hypertension. Eur Respir Rev. 2021;30(162):200330. doi:10.1183/16000617.0330-2020
   PubMed Web of Science ®Google Scholar
• Grabicki M, Kuźnar-Kamińska B, Rubinsztajn R, et al. COPD course and comorbidities: are there gender differences? Adv Exp Med Biol. 2019;1113:43–51.
   PubMed Web of Science ®Google Scholar
• Almagro P, López García F, Cabrera FJ, et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med. 2010;104(2):253–259. doi:10.1016/j.rmed.2009.09.019
   PubMed Web of Science ®Google Scholar
• Chung LP, Winship P, Phung S, Lake F, Waterer G. Five-year outcome in COPD patients after their first episode of acute exacerbation treated with non-invasive ventilation. Respirology. 2010;15(7):1084–1091. doi:10.1111/j.1440-1843.2010.01795.x
   PubMed Web of Science ®Google Scholar
• Pavasini R, d’Ascenzo F, Campo G, et al. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Cardiol. 2015;191:187–193. doi:10.1016/j.ijcard.2015.05.006
   PubMed Web of Science ®Google Scholar
• Frost A, Badesch D, Gibbs JSR, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53(1):1801904. doi:10.1183/13993003.01904-2018
   PubMed Web of Science ®Google Scholar
• Huang WC, Hsu CH, Sung SH, et al. 2018 TSOC guideline focused update on diagnosis and treatment of pulmonary arterial hypertension. J Formos Med Assoc. 2019;118(12):1584–1609. doi:10.1016/j.jfma.2018.12.009
   PubMed Web of Science ®Google Scholar
• Ni JR, Yan PJ, Liu SD, et al. Diagnostic accuracy of transthoracic echocardiography for pulmonary hypertension: a systematic review and meta-analysis. BMJ Open. 2019;9(12):e033084. doi:10.1136/bmjopen-2019-033084
   PubMed Web of Science ®Google Scholar
• Keir GJ, Wort SJ, Kokosi M, et al. Pulmonary hypertension in interstitial lung disease: limitations of echocardiography compared to cardiac catheterization. Respirology. 2018;23(7):687–694. doi:10.1111/resp.13250
   PubMed Web of Science ®Google Scholar
• D’Alto M, Bossone E, Opotowsky AR, Ghio S, Rudski LG, Naeije R. Strengths and weaknesses of echocardiography for the diagnosis of pulmonary hypertension. Int J Cardiol. 2018;263:177–183. doi:10.1016/j.ijcard.2018.04.024
   PubMed Web of Science ®Google Scholar
• Acharya V, Mugularao S, Seshadri S, Shetty RK. Assessment of diastolic dysfunction parameters and cardiac chamber size in smokers with COPD: a case control study. J Clin Diagn Res. 2018;12(1):45.
   Web of Science ®Google Scholar
• Aksu F, Capan N, Aksu K, et al. C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013;5(4):414–421. doi:10.3978/j.issn.2072-1439.2013.06.27
   PubMed Web of Science ®Google Scholar
• Alkukhun L, Baumgartner M, Budev M, Dweik RA, Tonelli AR. Electrocardiographic differences between COPD patients evaluated for lung transplantation with and without pulmonary hypertension. COPD. 2014;11(6):670–680. doi:10.3109/15412555.2014.898047
   PubMedGoogle Scholar
• Blanco I, Valeiro B, Torres-Castro R, et al. Effects of pulmonary hypertension on exercise capacity in patients with chronic obstructive pulmonary disease. Arch Bronconeumol. 2020;56(8):499–505. doi:10.1016/j.arbr.2019.10.018
   PubMed Web of Science ®Google Scholar
• Buklioska-Ilievska D, Minov J, Kochovska-Kamchevska N, et al. Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: echocardiography changes and their relation to the level of airflow limitation. Open Access Maced J Med Sci. 2019;7(21):3568–3573. doi:10.3889/oamjms.2019.848
   PubMedGoogle Scholar
• Chaouat A, Savale L, Chouaid C, et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest. 2009;136(3):678–687. doi:10.1378/chest.08-2420
   PubMed Web of Science ®Google Scholar
• Chen X, Liu K, Wang Z, et al. Computed tomography measurement of pulmonary artery for diagnosis of COPD and its comorbidity pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2015;10:2525–2533. doi:10.2147/COPD.S94211
   PubMed Web of Science ®Google Scholar
• Fayngersh V, Drakopanagiotakis F, Dennis McCool F, Klinger JR. Pulmonary hypertension in a stable community-based COPD population. Lung. 2011;189(5):377–382. doi:10.1007/s00408-011-9315-2
   PubMed Web of Science ®Google Scholar
• Freixa X, Portillo K, Paré C, et al. Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur Respir J. 2013;41(4):784–791. doi:10.1183/09031936.00222511
   PubMed Web of Science ®Google Scholar
• Gartman EJ, Blundin M, Klinger JR, Yammine J, Roberts MB, Dennis McCool F. Initial risk assessment for pulmonary hypertension in patients with COPD. Lung. 2012;190(1):83–89. doi:10.1007/s00408-011-9346-8
   PubMed Web of Science ®Google Scholar
• Gupta KK, Roy B, Chaudhary SC, et al. Prevalence of pulmonary artery hypertension in patients of chronic obstructive pulmonary disease and its correlation with stages of chronic obstructive pulmonary disease, exercising capacity, and quality of life. J Family Med Prim Care. 2018;7(1):53–57. doi:10.4103/jfmpc.jfmpc_18_17
   PubMedGoogle Scholar
• Halvani A, Haddad H. Comparison of the factors influencing pulmonary arterial pressure in smoker and non-smoker COPD patients with pulmonary hypertension. Tanaffos. 2019;18(1):41–46.
   PubMedGoogle Scholar
• Hayes D Jr, Tumin D, Budev MM, et al. Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation. Respir Med. 2017;128:102–108. doi:10.1016/j.rmed.2017.04.010
   PubMed Web of Science ®Google Scholar
• Hilde JM, Skjørten I, Hansteen V, et al. Assessment of right ventricular afterload in COPD. COPD. 2016;13(2):176–185. doi:10.3109/15412555.2015.1057275
   PubMedGoogle Scholar
• Jethani V, Sindhwani G. Chronic obstructive pulmonary disease and cardiac comorbidities: a cross-sectional study. Lung India. 2016;33(6):697. doi:10.4103/0970-2113.192866
   PubMedGoogle Scholar
• Kwon YS, Chi SY, Shin HJ, et al. Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension. J Korean Med Sci. 2010;25(10):1487–1491. doi:10.3346/jkms.2010.25.10.1487
   PubMed Web of Science ®Google Scholar
• Malinovschi A, Masoero M, Bellocchia M, et al. Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients. Respir Res. 2014;15(1):131.
   PubMed Web of Science ®Google Scholar
• Matsuyama W, Ohkubo R, Michizono K, et al. Usefulness of transcutaneous Doppler jugular venous echo to predict pulmonary hypertension in COPD patients. Eur Respir J. 2001;17(6):1128–1131. doi:10.1183/09031936.01.00088401
   PubMed Web of Science ®Google Scholar
• Mohamed Hoesein FA, Besselink T, Pompe E, et al. Accuracy of CT pulmonary artery diameter for pulmonary hypertension in end-stage COPD. Lung. 2016;194(5):813–819. doi:10.1007/s00408-016-9926-8
   PubMed Web of Science ®Google Scholar
• Mohamed MF, Ali A, Abbas A, Awad MS, Gouda M, Sediq AM. Mean platelet volume as a predictor of pulmonary hypertension in patients with stable COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:1099–1108. doi:10.2147/COPD.S176413
   PubMed Web of Science ®Google Scholar
• Nakahara Y, Taniguchi H, Kimura T, et al. Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia. Respirology. 2017;22(1):120–125. doi:10.1111/resp.12863
   PubMed Web of Science ®Google Scholar
• Nakayama S, Chubachi S, Sakurai K, et al. Characteristics of chronic obstructive pulmonary disease patients with pulmonary hypertension assessed by echocardiography in a three-year observational cohort study. Int J Chron Obstruct Pulmon Dis. 2020;15:487–499. doi:10.2147/COPD.S230952
   PubMed Web of Science ®Google Scholar
• Nathan SD, Barnett SD, King CS, et al. Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for organ sharing database. Pulm Circ. 2021;11(2):2045894021999960. doi:10.1177/2045894021999960
   Web of Science ®Google Scholar
• Portillo K, Torralba Y, Blanco I, et al. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1313–1320. doi:10.2147/COPD.S78180
   PubMed Web of Science ®Google Scholar
• Sertogullarindan B, Gumrukcuoglu HA, Sezgi C, Akil MA. Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smoke. Int J Med Sci. 2012;9(6):406–412. doi:10.7150/ijms.4715
   PubMed Web of Science ®Google Scholar
• Seyhan EC, Özgül MA, Tutar N, Ömür I, Uysal A, Altin S. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD. 2013;10(4):416–424. doi:10.3109/15412555.2012.758697
   PubMedGoogle Scholar
• El-Shabrawy M, Eldamanhory AS. Study of cardiovascular diseases in hospitalized AECOPD patients. Egypt J Chest Dis Tuberc. 2017;66(1):17–25. doi:10.1016/j.ejcdt.2016.08.008
   Web of Science ®Google Scholar
• Shin S, King CS, Brown AW, et al. Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease. Respir Med. 2014;108(11):1626–1632. doi:10.1016/j.rmed.2014.08.009
   PubMed Web of Science ®Google Scholar
• Sims MW, Margolis DJ, Localio AR, Panettieri RA, Kawut SM, Christie JD. Impact of pulmonary artery pressure on exercise function in severe COPD. Chest. 2009;136(2):412–419. doi:10.1378/chest.08-2739
   PubMed Web of Science ®Google Scholar
• Skjørten I, Hilde JM, Melsom MN, Hansteen V, Steine K, Humerfelt S. Pulmonary artery pressure and PaO2 in chronic obstructive pulmonary disease. Respir Med. 2013;107(8):1271–1279. doi:10.1016/j.rmed.2013.03.021
   PubMed Web of Science ®Google Scholar
• Sridhara VSHK, Acharya V. Comorbidities of chronic obstructive pulmonary disease and their affect on hospitalization of patients in a tertiary care hospital. J Community Hosp Intern Med Perspect. 2021;11(1):120–123. doi:10.1080/20009666.2020.1843823
   PubMed Web of Science ®Google Scholar
• Stolz D, Christ-Crain M, Morgenthaler NG, et al. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest. 2008;134(2):263–272.
   PubMed Web of Science ®Google Scholar
• Sun WL, Wang JL, Jia GH, et al. Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chin Med J. 2019;132(11):1272–1282. doi:10.1097/CM9.0000000000000247
   PubMed Web of Science ®Google Scholar
• Takahashi T, Yoshihisa A, Sugimoto K, et al. Associations between diabetes mellitus and pulmonary hypertension in chronic respiratory disease patients. PLoS One. 2018;13(10):e0205008. doi:10.1371/journal.pone.0205008
   PubMed Web of Science ®Google Scholar
• Xiong W, Zhao Y, Gong S, Zhao Q, Liu J. Prophylactic function of excellent compliance with LTOT in the development of pulmonary hypertension due to COPD with hypoxemia. Pulm Circ. 2018;8(2):2045894018765835. doi:10.1177/2045894018765835
   Web of Science ®Google Scholar
• Xiong M, Guo M, Huang D, Li J, Zhou Y. TRPV1 genetic polymorphisms and risk of COPD or COPD combined with PH in the Han Chinese population. Cell Cycle. 2020;19(22):3066–3073. doi:10.1080/15384101.2020.1831246
   PubMed Web of Science ®Google Scholar
• Yazici O, Tas Gulen S, Eryilmaz U, Omurlu IK. The evaluation of cardiac functions according to chronic obstructive pulmonary disease groups. Aging Male. 2020;23(2):106–111. doi:10.1080/13685538.2019.1606191
   PubMed Web of Science ®Google Scholar